ANAPTYSBIO, INC. (ANAB) Total liabilities 2016–2025
ANAPTYSBIO, INC. (ANAB) total liabilities at each fiscal year-end, per SEC filings.
$327.2MFY2025 · since FY2016: $100.4M → $327.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $327.2M | -20.8% |
| FY2024 | $413.0M | +13.4% |
| FY2023 | $364.3M | +4.6% |
| FY2022 | $348.3M | +21.5% |
| FY2021 | $286.6M | +1346.2% |
| FY2020 | $19.8M | -34.3% |
| FY2019 | $30.2M | +33.4% |
| FY2018 | $22.6M | +3.9% |
| FY2017 | $21.8M | -78.3% |
| FY2016 | $100.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice